IBDEI0V3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15335,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,15336,0)
 ;;=V16.3^^89^905^6
 ;;^UTILITY(U,$J,358.3,15336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15336,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,15336,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,15336,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,15337,0)
 ;;=V16.41^^89^905^9
 ;;^UTILITY(U,$J,358.3,15337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15337,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,15337,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,15337,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,15338,0)
 ;;=V16.42^^89^905^10
 ;;^UTILITY(U,$J,358.3,15338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15338,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,15338,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,15338,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,15339,0)
 ;;=V16.43^^89^905^11
 ;;^UTILITY(U,$J,358.3,15339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15339,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,15339,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,15339,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,15340,0)
 ;;=V19.5^^89^905^13
 ;;^UTILITY(U,$J,358.3,15340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15340,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,15340,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,15340,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,15341,0)
 ;;=V19.2^^89^905^14
 ;;^UTILITY(U,$J,358.3,15341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15341,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,15341,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,15341,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,15342,0)
 ;;=V17.3^^89^905^16
 ;;^UTILITY(U,$J,358.3,15342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15342,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,15342,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,15342,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,15343,0)
 ;;=V16.6^^89^905^17
 ;;^UTILITY(U,$J,358.3,15343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15343,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,15343,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,15343,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,15344,0)
 ;;=V18.61^^89^905^19
 ;;^UTILITY(U,$J,358.3,15344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15344,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,15344,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,15344,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,15345,0)
 ;;=V17.0^^89^905^20
 ;;^UTILITY(U,$J,358.3,15345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15345,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,15345,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,15345,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,15346,0)
 ;;=V19.4^^89^905^21
 ;;^UTILITY(U,$J,358.3,15346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15346,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,15346,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,15346,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,15347,0)
 ;;=V17.1^^89^905^22
 ;;^UTILITY(U,$J,358.3,15347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15347,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,15347,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,15347,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,15348,0)
 ;;=V16.8^^89^905^12
 ;;^UTILITY(U,$J,358.3,15348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15348,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,15348,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,15348,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,15349,0)
 ;;=V11.1^^89^905^24
